Odyssey Health (ODYY) Net Income towards Common Stockholders (2014 - 2026)
Odyssey Health's (ODYY) quarterly Net Income towards Common Stockholders came in at $765890.0 in Q2 2026, up 404.23% year-on-year from $151891.5 in Q2 2025, and up 228.86% quarter-over-quarter from -$594371.0 in Q1 2026.
Odyssey Health (ODYY) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends
Odyssey Health's Net Income towards Common Stockholders history runs 13 years deep, the most recent figure standing at $765890.0 for Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 404.23% year-over-year to $765890.0 in Q2 2026; TTM through Apr 2026 was -$478923.0, a 96.54% increase from a year earlier, with the FY2025 full-year figure at -$1.7 million, down 92.4% from the prior year.
- Net Income towards Common Stockholders climbed to $765890.0 in Q2 2026 per ODYY's latest filing, from -$594371.0 in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $13.2 million in Q1 2024 and bottomed at -$12.7 million in Q3 2024.
- The 5-year median for Net Income towards Common Stockholders is -$731108.5 (2023), against an average of -$826890.7.
- Biggest YoY gain for Net Income towards Common Stockholders was 890.45% in 2024; the steepest drop was 1465.03% in 2024.
- Year by year, Net Income towards Common Stockholders stood at -$2.1 million in 2022, then soared by 74.96% to -$538100.0 in 2023, then slipped by 20.46% to -$648208.0 in 2024, then soared by 38.52% to -$398526.0 in 2025, then jumped by 292.18% to $765890.0 in 2026.
- Per Business Quant, the three latest ODYY Net Income towards Common Stockholders figures stand at $765890.0 (Q2 2026), -$594371.0 (Q1 2026), and -$398526.0 (Q4 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | 765,890.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 765,890.00 |
| Jan 31, 2026 | -594,371.00 |
| Oct 31, 2025 | -398,526.00 |
| Jul 31, 2025 | -251,916.00 |
| Apr 30, 2025 | -251,743.00 |
| Jan 31, 2025 | -220,126.00 |
| Oct 31, 2024 | -648,208.00 |
| Jul 31, 2024 | -12.74 Mn |
| Apr 30, 2024 | -842,341.00 |
| Jan 31, 2024 | 13.21 Mn |
| Oct 31, 2023 | -538,100.00 |
| Jul 31, 2023 | -814,009.00 |
| Apr 30, 2023 | -1.28 Mn |
| Jan 31, 2023 | -1.67 Mn |
| Oct 31, 2022 | -2.15 Mn |
| Jul 31, 2022 | -1.18 Mn |
| Apr 30, 2022 | -3.10 Mn |
| Jan 31, 2022 | -2.18 Mn |
| Oct 31, 2021 | -1.65 Mn |
| Jul 31, 2021 | -2.58 Mn |